Login
Related Links
Gene Therapy Research Institutes - US & Canada
- Center for Cell and Gene Therapy, Baylor College of Medicine, Houston
- Center for Gene Therapy, University of Michigan Medical Center, Ann Arbor
- Dep. of Gene and Cell Medicine, Mount Sinai School of Medicine, New York
- Gene Therapy Center, University of North Carolina School of Medicine
- Harvard Gene Therapy Initiative, Harvard University, Boston
- Iowa Center for Gene Therapy, University of Iowa, Iowa City
- Mayo Clinic Department of Molecular Medicine
- Mayo Graduate School, Mayo Clinic, Virology and Gene Therapy Track, Rochester
- Minnesota University, Molecular and Cellular Therapeutics Program
- Penn Vector Core, University of Pennsylvania, Philadelphia
- Powell Gene Therapy Center, University of Florida, Gainesville
Collaboration between Baylor College of Medicine, The Methodist Hospital and Texas Children's Hospital. Clinical research in the areas of stem cell transplantation, cellular therapy, and gene therapy.
The Center fosters a multidisciplinary approach to new research as well as collaborative research endeavors in the area of gene therapy. The Vector Core manufactures several recombinant viral vectors.
The research is focused on various aspects of gene therapy, such as understanding basic virology, efficient gene delivery into the nucleus of cells, and incorporation of these genes into the genome.
Research in the laboratory has centered on the molecular biology of adeno-associated virus (AAV) in order to exploit the unique features of this virus to develop an efficient viral vector system for use in human gene therapy.
The Harvard Gene Therapy Initiative is headed by Dr. Richard Mulligan with the objective of promoting the use of gene therapy and to conduct research developing new gene delivery vector technologies.
Diseases of the lung, cardiovascular system, muscles, brain, and skin are focus areas of research as well as the development of gene therapy vectors and the identification of disease-causing genes.
A multidisciplinary team of scientists and physicians work together to realize the full potential of virus, gene and cell therapies from basic science discovery to clinical translation.
Oncolytic virotherapy, gene therapy for diabetes and cardiovascular diseases, virus-based gene therapy vectors.
The program has brought together regulatory, quality, product development, manufacturing and facilities engineering expertise to enable the translation of novel, experimental research into medicine for use in human clinical trials.
Penn Vector offers a variety of services associated with the development and production of both non-viral vectors and viral vectors including those derived from adeno-associated virus (AAV), adenovirus, and lentivirus.
The primary mission is to merge molecular genetics research and health care delivery by developing new therapeutic strategies for the treatment of human diseases that involve gene transfer.
Info Research Centers
Overview of research institutes, centers and universities involved in pre-clinical and clinical gene therapy research:
Check here also the European Union Framework Programme Six (FP6) Integrated Projects, such as Attack, Clinigene, Consert and GIANT.
See also the European Union Framework Programme Seven (FP7) Integrated Projects.
Your Research Institute not listed? Click here to suggest
Like to work for a research center? Find here the perfect job in gene therapy.
US & Canada | |
Europe | |
Australia |
Check here also the European Union Framework Programme Six (FP6) Integrated Projects, such as Attack, Clinigene, Consert and GIANT.
See also the European Union Framework Programme Seven (FP7) Integrated Projects.
Your Research Institute not listed? Click here to suggest
Like to work for a research center? Find here the perfect job in gene therapy.
Gene Therapy News
- Cell and Gene Therapy Bioassay Services Market Innovations Investigated by Future Scope and Latest Trends A... - WhaTech
Fri, 19 Apr 2024 06:00:2 GMT - Boy with rare blood disorder receives new life-changing gene therapy treatment - AOL
Fri, 19 Apr 2024 04:32:1 GMT - Long Island boy with rare blood disorder undergoes gene therapy - PIX11 New York News
Fri, 19 Apr 2024 01:39:1 GMT - New gene therapy eliminates need for bone marrow transplant. Here's how it works. - CBS News
Fri, 19 Apr 2024 00:35:0 GMT - Long Island boy undergoes groundbreaking gene therapy - CBS New York - CBS New York
Fri, 19 Apr 2024 00:35:0 GMT - Gene Therapy Stops Cancer: Will It Tackle Brain Tumors? - Mirage News
Thu, 18 Apr 2024 23:32:0 GMT - Ferring taps CDMO SK pharmteco to boost long-term supply of gene therapy Adstiladrin - FiercePharma
Thu, 18 Apr 2024 23:12:4 GMT - Medical breakthrough: 8-year-old boy first in New York to receive FDA-approved gene therapy for rare inherited blood disorder - WABC-TV
Thu, 18 Apr 2024 22:56:0 GMT - Hospital gives first dose of gene therapy for DMD in WV - WDTV
Thu, 18 Apr 2024 21:47:0 GMT - Gene Therapy Market Size Poised to Surge USD 52.40 Billion by 2033 - BioSpace
Thu, 18 Apr 2024 21:12:5 GMT - Cancer Gene Therapy Industry is Rising Rapidly Up to USD 18.11 Bn by 2033 - BioSpace
Thu, 18 Apr 2024 21:09:1 GMT - Cell and Gene Therapy Clinical Trials Market Experiencing Rapid Growth 15.09% - BioSpace
Thu, 18 Apr 2024 20:53:3 GMT - AskBio Receives FDA Fast Track Designation for AB-1002 Investigational Gene Therapy Program in Congestive Heart ... - Diagnostic and Interventional Cardiology
Thu, 18 Apr 2024 20:38:0 GMT - Gene therapy to treat congestive heart failure gains FDA fast track designation - Healio
Thu, 18 Apr 2024 19:39:3 GMT - 8-year-old from Valley Stream becomes first in NY to undergo gene therapy for rare disease - News 12 Long Island
Thu, 18 Apr 2024 19:37:4 GMT